[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-371107-105":59,"doc-detail-371107-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","noncoding-rnas-and-dna-methylation-as-epigenetic-modulators-of-breast-cancer-mechanisms-and-clinical-perspectives-in-the-iranian-population","Noncoding RNAs and DNA methylation as epigenetic modulators of breast cancer - mechanisms and clinical perspectives in the Iranian population","","Noncoding RNAs (ncRNAs)—including microRNAs, long noncoding RNAs, and circular RNAs—regulate gene expression and influence breast cancer development through epigenetic mechanisms. Their dysregulation is linked to initiation, progression, metastasis, and therapeutic resistance. DNA methylation represents another epigenetic pathway affecting cancer susceptibility. Using PRISMA-guided searches of PubMed, Scopus, IranMedex, and Magiran (2019–2024), the review identifies altered ncRNAs and methylation patterns associated with breast cancer risk and molecular changes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/noncoding-rnas-and-dna-methylation-as-epigenetic-modulators-of-breast-cancer-mechanisms-and-clinical-perspectives-in-the-iranian-population/371107/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/noncoding-rnas-and-dna-methylation-as-epigenetic-modulators-of-breast-cancer-mechanisms-and-clinical-perspectives-in-the-iranian-population/371107.png","ImageObject",300,407,{"name":92,"@type":93},"CatatanPagi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What epigenetic roles do noncoding RNAs play in breast cancer?","Question",{"text":112,"@type":113},"Noncoding RNAs regulate gene expression and influence breast cancer development. Their dysregulation is associated with tumor initiation, progression, metastasis, and therapy resistance.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the systematic review conducted?",{"text":117,"@type":113},"Following PRISMA guidelines, studies published between 2019 and 2024 were searched in PubMed, Scopus, IranMedex, and Magiran. Eligible studies examined roles of ncRNAs and/or DNA methylation in breast cancer.",{"name":119,"@type":110,"acceptedAnswer":120},"Which DNA methylation patterns and biomarkers are highlighted?",{"text":121,"@type":113},"Aberrant DNA methylation of genes such as PGR, ISL1, and MGMT is associated with altered gene expression and increased breast cancer risk. The review also emphasizes specific ncRNAs (e.g., MALAT1, miR-605, circ_0005046) for diagnostic and prognostic potential.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},371107,1790217016,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090894170,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Mashayekh etal. BMC Cancer (2026) 26:122 BMC Cancer  \n[https://doi.org/10.1186/s12885-025-15430-z](https://doi.org/10.1186/s12885-025-15430-z)  \nRESEARCH Open Access  \nNoncoding RNAs and DNA methylation as epigenetic modulators of breast cancer: mechanisms and clinical perspectives in the Iranian population, a systematic review  \nZeynab Mashayekh 1, Rasool Fatehi Fard2 and Sadeq Val lian 1*  \nAbstract  \nObjective Noncoding RNAs (ncRNAs), including microRNAs (miRNAs), long noncoding RNAs (lncRNAs), and circular RNAs (circRNAs), play critical epigenetic roles in regulating gene expression and cancer development. Dysregulation of these molecules is closely associated with breast cancer initiation, progression, metastasis, and therapeutic resistance. Another major epigenetic mechanism, DNA methylation, also contributes to cancer susceptibility. Methods Following PRISMA guidelines, a systematic search was conducted in PubMed, Scopus, IranMedex, and Magiran for studies published between 2019 and 2024. Eligible studies investigated the roles of ncRNAs and/or DNA methylation in breast cancer. Data extraction and study selection were performed according to predefined inclusion criteria.  \nResults The study identified several dysregulated ncRNAs, including miR-155, miR-605, ZEB2-AS1, MALAT1, AK058003, SGO-AS1, and circ_0005046, that regulate key cellular processes including apoptosis, proliferation, invasion, and therapy resistance. Additionally, aberrant DNA methylation of genes such as PGR, ISL1, and MGMTwas associated with altered gene expression and an increased risk of breast cancer.  \nConclusion Both ncRNAs and DNA methylation demonstrate strong potential as diagnostic and prognostic biomarkers with clinical relevance in breast cancer. To our knowledge, this is the first systematic review to integrate findings from both international and Iranian studies, providing a comprehensive overview of epigenetic regulation in breast cancer.  \nHighlights  \n• Noncoding RNAs (miRNAs, lncRNAs, circRNAs) act as key epigenetic regulators in breast cancer.  \n• Dysregulated ncRNAs modulate apoptosis, proliferation, metastasis, and therapy resistance.  \n• Aberrant DNA methylation of tumor-related genes (PGR, ISL1, MGMT) contributes to cancer susceptibility.  \n• Specific ncRNAs (MALAT1, HOTAIR, miR-605, circ_ 0005046) show strong diagnostic and prognostic potential.  \n*Correspondence: Sadeq Val lian [svall ian@sci.ui.ac.ir](svall ian@sci.ui.ac.ir)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nMashayekh et al. BMC Cancer (2026) 26:122 Page 2 of 18  \n• Integration of ncRNAs and DNA methylation markers may advance personalized, epigenetically targeted therapies.  \nKeywords Noncoding RNAs, MicroRNAs, Long-noncoding RNAs, Circular RNAs, Epigenetic modifiers, Breast cancer  \nIntroduction  \nBreast cancer remains one of the most significant global health challenges, a","cbCaiksGNQk9Xtla","https://ap.wps.com/l/cbCaiksGNQk9Xtla","pdf",2012895,18,"English","# Abstract\n## Objective\n## Methods\n## Results\n## Conclusion\n# Highlights\n# Keywords\n# Introduction\n## Breast cancer burden and Iran context\n## Epigenetics and ncRNAs\n## Rationale for epigenetic marker research","[{\"question\":\"What epigenetic roles do noncoding RNAs play in breast cancer?\",\"answer\":\"Noncoding RNAs regulate gene expression and influence breast cancer development. Their dysregulation is associated with tumor initiation, progression, metastasis, and therapy resistance.\"},{\"question\":\"How was the systematic review conducted?\",\"answer\":\"Following PRISMA guidelines, studies published between 2019 and 2024 were searched in PubMed, Scopus, IranMedex, and Magiran. Eligible studies examined roles of ncRNAs and/or DNA methylation in breast cancer.\"},{\"question\":\"Which DNA methylation patterns and biomarkers are highlighted?\",\"answer\":\"Aberrant DNA methylation of genes such as PGR, ISL1, and MGMT is associated with altered gene expression and increased breast cancer risk. The review also emphasizes specific ncRNAs (e.g., MALAT1, miR-605, circ_0005046) for diagnostic and prognostic potential.\"}]","Noncoding RNAs and DNA methylation as epigenetic modulators of breast cancer - mechanisms and clinical perspectives in the Iranian population | PDF",1790191263,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/39566e1ef6204be0eec90b4c5d724b28.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d525299818e1265e726116b774bb17a0.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/558270473b197a41b8a8f0221f42009e.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7b7ef94dde8d02369417aeca7c524fd3.webp",980,1306]